Emerging small molecule antivirals may fit neatly into COVID-19 treatment

Numerous treatments exist for COVID-19, the illness caused by SARS-CoV-2 virus, although most are not well established; among these are several small molecule antiviral agents. Intravenous remdesivir is an established treatment worldwide for inpatients and in some countries is also available for use...

Descripción completa

Detalles Bibliográficos
Autores principales: Fenton, Caroline, Keam, Susan J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
Practical Issues and Updates
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882464/
https://www.ncbi.nlm.nih.gov/pubmed/35250258
http://dx.doi.org/10.1007/s40267-022-00897-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8882464/
https://www.ncbi.nlm.nih.gov/pubmed/35250258
http://dx.doi.org/10.1007/s40267-022-00897-8

Ejemplares similares